CYP2C19 polymorphism and risk for essential tremor

被引：0
|
作者：
Alonso-Navarro, H.
Martinez, C.
Garcia-Martin, E.
Benito-Leon, J.
Garcia-Ferrer, I.
Vazquez-Torres, P.
Puertas, I.
Lopez-Alburquerqe, T.
Agundez, J. A. G.
Jimenez-Jimenez, F. J.
机构：
[1] Univ Alcala de Henares, Hosp Principe Asturias, Madrid, Spain
[2] Univ Extremadura, Dept Pharmacol & Psychiat, Badajoz, Spain
[3] Univ Extremadura, Dept Biochem & Mol Biol, Badajoz, Spain
[4] Hosp Mostoles, Neurol Sect, Mostoles, Spain
[5] Univ Hosp Salamanca, Neurol Sect, Salamanca, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [21] The effect of CYP2C19 and CYP2C9 polymorphism on the pharmacodynamics of clopidogrel
    Jiang, Juanjuan
    Tian, Lei
    Han, Lulu
    Yan, Yan
    Huang, Yiling
    Liu, Hong
    Xie, Shuang
    Li, Yishi
    CARDIOLOGY, 2011, 120 : 30 - 31
  • [22] DISTRIBUTION OF THE CYP2C19*2, CYP2C19*3 AND CYP2C19*4 GENE VARIANTS IN A ROMANIAN POPULATION
    Buzoianu, A. D.
    Trifa, A. P.
    Popp, R. A.
    Militaru, C. F.
    Bocsan, C., I
    Popp, I., V
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 80 - 80
  • [23] In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease
    Ohnishi, A
    Murakami, S
    Akizuki, S
    Mochizuki, J
    Echizen, H
    Takagi, I
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (11): : 1221 - 1229
  • [24] The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases
    Alonso-Navarro, Hortensia
    Jimenez-Jimenez, Felix J.
    Garcia-Agundez, Jose A.
    MEDICINA CLINICA, 2006, 126 (18): : 697 - 706
  • [25] Gender Differences in Impact of CYP2C19 Polymorphism on Risk of Coronary Artery Disease
    Hokimoto, Seiji
    Akasaka, Tomonori
    Nakagawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [26] Rapid CYP2C19 Genotype Testing: Comparison between Spartan RX CYP2C19 and Verigene CYP2C19
    Zhou, Y.
    Armstead, A. R.
    Coshatt, G. M.
    Brott, B. C.
    Sankaranarayanan, A.
    Limdi, N. A.
    Harada, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 845 - 845
  • [27] Association Between CYP2C19 Polymorphism and Depressive Symptoms
    Sim, Sarah C.
    Nordin, Linn
    Andersson, Therese M. -L.
    Virding, Susanne
    Olsson, Marita
    Pedersen, Nancy L.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (06) : 1160 - 1166
  • [28] CYP2C19 polymorphism in Korean patients on warfarin therapy
    Lee, Sukhyang
    Hwang, Hyun Jin
    Kim, Jae-Moon
    Chung, Chin-Sang
    Kim, Jeong Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (03) : 344 - 349
  • [29] CYP2C19 polymorphism influences Helicobacter pylori eradication
    Chao-Hung Kuo
    Chien-Yu Lu
    Hsiang-Yao Shih
    Chung-Jung Liu
    Meng-Chieh Wu
    Huang-Ming Hu
    Wen-Hung Hsu
    Fang-Jung Yu
    Deng-Chyang Wu
    Fu-Chen Kuo
    World Journal of Gastroenterology, 2014, 20 (43) : 16029 - 16036
  • [30] CYP2C19 polymorphism influences Helicobacter pylori eradication
    Kuo, Chao-Hung
    Lu, Chien-Yu
    Shih, Hsiang-Yao
    Liu, Chung-Jung
    Wu, Meng-Chieh
    Hu, Huang-Ming
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Wu, Deng-Chyang
    Kuo, Fu-Chen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (43) : 16029 - 16036
12345